Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients [Phase 4]
A Phase 4 trial comparing bisoprolol with metoprolol succinate SR in hypertensive patients assessed heart rate and blood pressure; results h…
-
CLINICAL_TRIALS withdrawal · 2015-05-08Clinical Trial Update: Project Wellness: Increasing HIV Testing Among West African Immigrants [NA]
The clinical trial 'Project Wellness: Increasing HIV Testing Among West African Immigrants' (NCT01270061) has been withdrawn. The study refe…
-
FDA label_change · 2015-05-06FDA Approved: GUANFACINE — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
FDA approved a supplemental application for guanfacine from PuraCap Laboratories dba Blu Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil in combination with metformin for hypertension and diabetes. The st…
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: Perioperative Baroreflex Sensitivity
An update on a clinical trial studying perioperative baroreflex sensitivity, sponsored by RenJi Hospital. The reported conditions include hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Blood Pressure Change and Outcome
A completed clinical trial update reporting blood pressure changes and outcomes in participants with renal disease and hypertension.
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Irbesartan and Atenolol in Hypertensive Heart Disease [Phase 2, Phase 3]
Phase 2/3 trial evaluating irbesartan and atenolol in hypertensive heart disease has completed, with results posted in 2015.
-
FDA approval · 2015-05-04FDA Approved: TRANDOLAPRIL — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for Trandolapril tablets from Epic Pharma, LLC, indicating regulatory approval for the requested cha…
-
FDA approval · 2015-05-01FDA Approved: TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for the combination drug trandolapril and verapamil hydrochloride.
-
FDA approval · 2015-05-01FDA Approved: ENALAPRIL MALEATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for enalapril maleate from ScieGen Pharmaceuticals, indicating continued/expanded authorization …
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Nebivolol in the Supine Hypertension of Autonomic Failure [NA]
Clinical trial update shows a completed study of Nebivolol for supine hypertension in autonomic failure with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Predisposition and Transition Mechanisms From Arterial Hypertension to Heart Failure [NA]
A clinical study investigating predisposition and transition mechanisms from arterial hypertension to heart failure has completed; no effica…
-
FDA approval · 2015-04-28FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for benazepril hydrochloride submitted by Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Developing Accessible Telehealth Programs for Hypertensive Patients in Latin America [NA]
A completed clinical trial conducted by the University of Michigan evaluated developing accessible telehealth programs for hypertensive pati…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Stroke Health and Risk Education (SHARE) [NA]
Update on the Stroke Health and Risk Education (SHARE) trial; the study evaluating stroke risk education in individuals with stroke or hyper…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Alberta Clinical Trial in Optimizing Hypertension [NA]
This clinical trial update notes a completed hypertension study conducted in Alberta and sponsored by the University of Alberta.
-
FDA approval · 2015-04-28FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for the generic fixed-dose combination of irbesartan and hydrochlorothiazide manufactured by Sol…
-
FDA approval · 2015-04-26FDA Approved: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril hydrochloride/hydrochlorothiazide from Aurobindo Pharma Limited.
-
FDA approval · 2015-04-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone from Mylan Pharmaceuticals Inc., indicating an approved change to an already-appr…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension [Phase 4]
A Phase 4 clinical trial evaluating spironolactone for resistant hypertension in Cameroonian patients with diabetes mellitus has completed.
-
FDA approval · 2015-04-24FDA Approved: TRANDOLAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic Trandolapril product from Aurobindo Pharma Limited.
-
FDA approval · 2015-04-22FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corp…
-
FDA approval · 2015-04-22FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for benazepril hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Community-based Approaches to Treating Hypertension and Colon Cancer Prevention [NA]
NYU Langone Health sponsored a community-based trial addressing hypertension control and colon cancer prevention that has completed. The stu…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol [Phase 4]
Phase 4 clinical trial update examining tight hemodynamic control in patients chronically on metoprolol; the study has been terminated.